Navigation Links
Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference
Date:12/13/2012

MONMOUTH JUNCTION, N.J., Dec. 13, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need who are battling serious orphan lung diseases, today announced that the Company will be participating in the 31st Annual J.P. Morgan Healthcare Conference from January 7-10, 2013 at the Westin St. Francis Hotel in San Francisco.  Will Lewis, Insmed's President and CEO, will present a corporate overview on Thursday, January 10th at 1:30 p.m. Pacific time (4:30 p.m. Eastern time). 

A live audio webcast of Mr. Lewis' presentation will be made available in the Investor section of Insmed's website, http://www.insmed.com where it will be archived for 90 days.

Insmed management will be available for one-on-one meetings with investors and analysts throughout the conference from January 7-10, 2013.  To schedule an appointment, contact Anne Marie Fields of LHA at 212-838-3777 or afields@lhai.com or contact your J.P. Morgan representative.

About Insmed

Insmed Incorporated is a biopharmaceutical company dedicated to improving the lives of patients battling serious orphan lung diseases through the development and commercialization of novel, targeted inhalation therapies in orphan patient populations with critical unmet needs. Insmed's lead candidate, ARIKACE®, is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the efficacy, safety and convenience of treatment for at least two identified patient populations: cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). Following positive phase 2 results in CF patients, Insmed's p
'/>"/>

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Insmed Incorporated Provides Corporate Update
2. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
3. Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012
4. Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference
5. Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
6. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
7. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
8. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
9. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
10. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
11. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 The next ... September 9th, 2014 and will comprise of the increasingly ... classes. The TechTrainings is a series of technical hands-on ... to help them reach the next step in their ... is taught by Jennifer Kang, Senior Statistician at ...
(Date:7/21/2014)... chemist in Syracuse University,s College of Arts and ... the synthesis of stainless nanoparticles. , Mathew M. ... a three-year, $360,000 grant from the National Science ... with metal stainless alloy nanostructures, the results of ... rechargeable lithium-ion batteries. , Maye,s approach ...
(Date:7/20/2014)... fuel gets recycled, the process releases radioactive krypton and ... with the related gas radon. A new porous material ... July 20 in Nature Materials shows how: ... not out. , The CC3 material could be ... nuclear fuel or air in buildings and also in ...
(Date:7/18/2014)... Researchers at the University of Illinois at Urbana-Champaign ... pillar-bowtie nanoantennas (pBNAs) can be used like traditional ... are much smaller than the wavelength of light ... red light). A standard optical microscope acts as ... film. , "Unlike conventional photographic film, the effect ...
Breaking Biology Technology:Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2A noble gas cage 2A noble gas cage 3'Nanocamera' takes pictures at distances smaller than light's own wavelength 2
... SHANGHAI, China, April 30 /Xinhua-PRNewswire/ -- Today, ... and NovaSecta in,their CRO Service Alliance CROSA ... companies. Tigermed,s expertise in clinical,development complements the ... the alliance., Sundia Meditech, United PharmaTech, ...
... add ... ... TSX symbol: SBS, CALGARY, April 30 /PRNewswire-FirstCall/ - Botaneco, a wholly-owned,subsidiary ... Croda Enterprise Technology, part of Croda,International Plc, an international manufacturer of speciality ingredients,with ...
... For-Profit Healthcare Companies, EL SEGUNDO, Calif., April ... care services, announced it has been honored for,the ... of the Top 125,ranking companies of employee-sponsored workforce ... that demonstrate a deep,commitment to learning and development ...
Cached Biology Technology:Shanghai CRO Service Alliance Adds Clinical Development Capabilities 2Shanghai CRO Service Alliance Adds Clinical Development Capabilities 3Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 2Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 3DaVita Honored for 4th Year as Training Top 125 Recipient 2
(Date:7/21/2014)... often results from the strength of immune response, rather ... rather than attacking the virus, might be a better ... the University of Washington, Seattle. She and her collaborators ... that for the H7N9 influenza, and their work has ... this highly virulent strain. The research is published ahead ...
(Date:7/21/2014)... Urban stormwater runoff is causing problems for the ... Environmental Protection Agency found stormwater runoff to be ... environments in rivers, streams, lakes, ponds, reservoirs, bays, ... can harm fish and wildlife populations, foul drinking ... from North Carolina State University are looking to ...
(Date:7/21/2014)... of life are now being developed to try and ... of species. Specifically, a recent model proposed by Petri ... accounts for species interactions with various degrees of symmetry, ... previous, simpler models, which apply random fitness levels to ... demonstrate that the resulting replicator ecosystems do not appear ...
Breaking Biology News(10 mins):Potential new flu drugs target immune response, not virus 2Filter bed substrates, plant types recommended for rain gardens 2Refined biological evolution model 2
... Data publishers should have the option of submitting their ... paper commissioned by the Global Biodiversity Information Facility (GBIF). ... recommendations made by Mark Costello and co-authors in the ... biodiversity data publication , freely available for download ...
... cells from patients with inherited heart muscle disease can ... to patients, including the possibility of testing new treatments ... cell model matches that of the clinical features of ... disease associated with sudden cardiac death Landmark study published ...
... more than 6,000 species of frogs in the world lay ... eggs out of water. This behavior protects the eggs from ... their risk of drying out. Justin Touchon, post-doctoral fellow at ... Panama may be altering frogs, course of evolution. By analyzing ...
Cached Biology News:Peer review option proposed for biodiversity data 2National Heart Centre Singapore develops world's first human heart cell model 2National Heart Centre Singapore develops world's first human heart cell model 3
MMP-1/8 (H-300)...
Gastric Carcinoma Marker [BY-1 (3H11)]...
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Mouse VEGF R1/Flt-1 Allophycocyanin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Biology Products: